Back to Results
First PageMeta Content
Pharmaceutical industry / Pharmacology / Drug safety / Health / Pharmaceuticals policy / Regulatory requirement / Pharmacovigilance / Clinical trial / International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use / Clinical research / Pharmaceutical sciences / Research


INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE PERIODIC BENEFIT-RISK EVALUATION REPORT (PBRER)
Add to Reading List

Document Date: 2014-04-10 10:33:50

Open Document

File Size: 799,02 KB

Share Result on Facebook

Company

ICH Expert Working Group / /

Country

Japan / United States / /

Event

FDA Phase / /

IndustryTerm

data mining techniques / medicinal product / proactive and documented risk management / fixed-dose combination product / medicinal products / generic product / established/generic products / /

MedicalCondition

IBD / severe liver injury / /

MedicalTreatment

Medication Errors / /

Organization

European Union / /

Product

R1 / Shure E2c Headphone/Headset / R2 / Guideline E2E / Guideline E2F / E2F / Guideline E2C(R1) / Guideline E2C / E2C / E2E / Adverse Drug / /

Technology

data mining / DLP / /

SocialTag